Nektar Therapeutics
NKTR·640268306·US·Common Stock·Healthcare - Biotechnology-13D/G
NKTR (Nektar Therapeutics) is held by 120 institutional investors as of Q2 2026. Largest holders: FMR LLC ($353.8M), BlackRock, Inc. ($205.4M), VANGUARD CAPITAL MANAGEMENT LLC ($104.5M). Net institutional sentiment: Bullish.
120
Holders
(6 Elite)
$1.4B
Total Value
71% (129)
Consensus
92 buying - 37 selling
13F: Insider & Congress: Updated regularly
Who's Trading
Source dates: Price Aug 28, 2026 · Insiders Aug 20, 2026 · Activists Aug 14, 2026 · Congress none
InsiderRWROBIN HOWARD WSell $30KAug 18, 2026
InsiderZJZalevsky JonathanSell $13KAug 18, 2026
ActivistBLBVF PARTNERS L P/IL7.1%Aug 14, 2026
Checking access…
Top Holders
Checking access…
Showing 1-20 of 135
1 / 7
Continue exploring
Other Healthcare stocks held by institutions
403 holders · $856.6B
403 holders · $286.8B
388 holders · $148B
385 holders · $405.5B
384 holders · $95B
381 holders · $105.8B
378 holders · $226B
375 holders · $51.2B
373 holders · $296.3B
371 holders · $110.7B
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer